Priyangika Senevirathne

Title: Innovations in Opioid Reversal: The Work of Priyangika Senevirathne

Introduction

Priyangika Senevirathne is an innovative inventor based in Cincinnati, OH. He has made significant contributions to the field of medicine, particularly in the area of opioid overdose treatment. His work focuses on developing long-lasting opioid reversal agents that can effectively respond to overdose situations.

Latest Patents

Senevirathne holds a patent for a formulation titled "Long lasting opioid reversal using hydrogen peroxide-induced release in blood." This patent discloses Naloxone variants that are both long-lasting and responsive. One version of the compound features a boron ester functional group, allowing for a sustained release of the antagonist based on its reaction with hydrogen peroxide. The method of treating opioid overdose involves administering a therapeutically effective amount of this formulation to patients in need. Administration can occur intranasally, sublingually, or through a combination of both methods, ensuring flexibility in treatment.

Career Highlights

Senevirathne is affiliated with the University of Cincinnati, where he continues to advance his research and innovations. His work is crucial in addressing the ongoing opioid crisis, providing new solutions that can save lives.

Collaborations

He collaborates with Steve Davidson, contributing to the development of effective treatments for opioid overdose. Their combined expertise enhances the potential impact of their research.

Conclusion

Priyangika Senevirathne's innovative work in opioid reversal represents a significant advancement in medical science. His contributions are vital in the fight against opioid overdoses, showcasing the importance of research and innovation in healthcare.